![Brandon Huffman: Exciting translational work happening at Dana-Farber Cancer Institute](https://oncodaily.com/pub/uploads/2024/02/7221818dbe7b4288abf11481f5ca7654-e1707222162280.jpg)
Photo from Brandon Huffman/X
Feb 19, 2024, 09:20
Brandon Huffman: Exciting translational work happening at Dana-Farber Cancer Institute
Brandon Huffman, Medical Oncologist in the Gastrointestinal Cancer Center at Dana-Farber Cancer Institute, shared an X post by James Cleary, Medical Oncologist in the Gastrointestinal Cancer Center at Dana-Farber Cancer Institute, adding:
“Congratulations to Harsh Singh, James Cleary, and the team on a very well-done description of the unique entity – HER2 (ERBB2) amplified CRC! Exciting translational work happening at Dana-Farber Cancer Institute!”
Quoting James Cleary’s post:
“In this collaboration with Harsh Singh, Lab Sethi, Jason Hornick we examined mechanisms of resistance and sensitivity to targeted therapy in HER2 amplified colorectal cancer.”
Proceed to the article.
Source: Brandon Huffman/X and James Cleary/X